Expression Competent Cells Market - Global Outlook and Forecast 2021-2027

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Expression Competent Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Expression Competent Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Expression Competent Cells Overall Market Size
2.1 Global Expression Competent Cells Market Size: 2021 VS 2027
2.2 Global Expression Competent Cells Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Expression Competent Cells Players in Global Market
3.2 Top Global Expression Competent Cells Companies Ranked by Revenue
3.3 Global Expression Competent Cells Revenue by Companies
3.4 Top 3 and Top 5 Expression Competent Cells Companies in Global Market, by Revenue in 2020
3.5 Global Companies Expression Competent Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Expression Competent Cells Players in Global Market
3.6.1 List of Global Tier 1 Expression Competent Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Expression Competent Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Expression Competent Cells Market Size Markets, 2021 & 2027
4.1.2 Chemically Competent Cells
4.1.3 Electrocompetent Cells
4.2 By Type - Global Expression Competent Cells Revenue & Forecasts
4.2.1 By Type - Global Expression Competent Cells Revenue, 2016-2021
4.2.2 By Type - Global Expression Competent Cells Revenue, 2022-2027
4.2.3 By Type - Global Expression Competent Cells Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Expression Competent Cells Market Size, 2021 & 2027
5.1.2 Protein Expression
5.1.3 Other
5.2 By Application - Global Expression Competent Cells Revenue & Forecasts
5.2.1 By Application - Global Expression Competent Cells Revenue, 2016-2021
5.2.2 By Application - Global Expression Competent Cells Revenue, 2022-2027
5.2.3 By Application - Global Expression Competent Cells Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Expression Competent Cells Market Size, 2021 & 2027
6.2 By Region - Global Expression Competent Cells Revenue & Forecasts
6.2.1 By Region - Global Expression Competent Cells Revenue, 2016-2021
6.2.2 By Region - Global Expression Competent Cells Revenue, 2022-2027
6.2.3 By Region - Global Expression Competent Cells Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Expression Competent Cells Revenue, 2016-2027
6.3.2 US Expression Competent Cells Market Size, 2016-2027
6.3.3 Canada Expression Competent Cells Market Size, 2016-2027
6.3.4 Mexico Expression Competent Cells Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Expression Competent Cells Revenue, 2016-2027
6.4.2 Germany Expression Competent Cells Market Size, 2016-2027
6.4.3 France Expression Competent Cells Market Size, 2016-2027
6.4.4 U.K. Expression Competent Cells Market Size, 2016-2027
6.4.5 Italy Expression Competent Cells Market Size, 2016-2027
6.4.6 Russia Expression Competent Cells Market Size, 2016-2027
6.4.7 Nordic Countries Expression Competent Cells Market Size, 2016-2027
6.4.8 Benelux Expression Competent Cells Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Expression Competent Cells Revenue, 2016-2027
6.5.2 China Expression Competent Cells Market Size, 2016-2027
6.5.3 Japan Expression Competent Cells Market Size, 2016-2027
6.5.4 South Korea Expression Competent Cells Market Size, 2016-2027
6.5.5 Southeast Asia Expression Competent Cells Market Size, 2016-2027
6.5.6 India Expression Competent Cells Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Expression Competent Cells Revenue, 2016-2027
6.6.2 Brazil Expression Competent Cells Market Size, 2016-2027
6.6.3 Argentina Expression Competent Cells Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Expression Competent Cells Revenue, 2016-2027
6.7.2 Turkey Expression Competent Cells Market Size, 2016-2027
6.7.3 Israel Expression Competent Cells Market Size, 2016-2027
6.7.4 Saudi Arabia Expression Competent Cells Market Size, 2016-2027
6.7.5 UAE Expression Competent Cells Market Size, 2016-2027
7 Players Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Corporate Summary
7.1.2 Merck KGaA Business Overview
7.1.3 Merck KGaA Expression Competent Cells Major Product Offerings
7.1.4 Merck KGaA Expression Competent Cells Revenue in Global (2016-2021)
7.1.5 Merck KGaA Key News
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Corporate Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Expression Competent Cells Major Product Offerings
7.2.4 Thermo Fisher Scientific Expression Competent Cells Revenue in Global (2016-2021)
7.2.5 Thermo Fisher Scientific Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Expression Competent Cells Major Product Offerings
7.3.4 Agilent Technologies Expression Competent Cells Revenue in Global (2016-2021)
7.3.5 Agilent Technologies Key News
7.4 Takara Bio
7.4.1 Takara Bio Corporate Summary
7.4.2 Takara Bio Business Overview
7.4.3 Takara Bio Expression Competent Cells Major Product Offerings
7.4.4 Takara Bio Expression Competent Cells Revenue in Global (2016-2021)
7.4.5 Takara Bio Key News
7.5 Promega Corporation
7.5.1 Promega Corporation Corporate Summary
7.5.2 Promega Corporation Business Overview
7.5.3 Promega Corporation Expression Competent Cells Major Product Offerings
7.5.4 Promega Corporation Expression Competent Cells Revenue in Global (2016-2021)
7.5.5 Promega Corporation Key News
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Corporate Summary
7.6.2 Beijing TransGen Biotech Business Overview
7.6.3 Beijing TransGen Biotech Expression Competent Cells Major Product Offerings
7.6.4 Beijing TransGen Biotech Expression Competent Cells Revenue in Global (2016-2021)
7.6.5 Beijing TransGen Biotech Key News
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Corporate Summary
7.7.2 GeneScript Corporation Business Overview
7.7.3 GeneScript Corporation Expression Competent Cells Major Product Offerings
7.4.4 GeneScript Corporation Expression Competent Cells Revenue in Global (2016-2021)
7.7.5 GeneScript Corporation Key News
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Corporate Summary
7.8.2 Yeastern Biotech Business Overview
7.8.3 Yeastern Biotech Expression Competent Cells Major Product Offerings
7.8.4 Yeastern Biotech Expression Competent Cells Revenue in Global (2016-2021)
7.8.5 Yeastern Biotech Key News
7.9 New England Biolabs
7.9.1 New England Biolabs Corporate Summary
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Expression Competent Cells Major Product Offerings
7.9.4 New England Biolabs Expression Competent Cells Revenue in Global (2016-2021)
7.9.5 New England Biolabs Key News
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Corporate Summary
7.10.2 QIAGEN N.V. Business Overview
7.10.3 QIAGEN N.V. Expression Competent Cells Major Product Offerings
7.10.4 QIAGEN N.V. Expression Competent Cells Revenue in Global (2016-2021)
7.10.5 QIAGEN N.V. Key News
7.11 OriGene Technologies
7.11.1 OriGene Technologies Corporate Summary
7.11.2 OriGene Technologies Business Overview
7.11.3 OriGene Technologies Expression Competent Cells Major Product Offerings
7.11.4 OriGene Technologies Expression Competent Cells Revenue in Global (2016-2021)
7.11.5 OriGene Technologies Key News
7.12 Lucigen
7.12.1 Lucigen Corporate Summary
7.12.2 Lucigen Business Overview
7.12.3 Lucigen Expression Competent Cells Major Product Offerings
7.12.4 Lucigen Expression Competent Cells Revenue in Global (2016-2021)
7.12.5 Lucigen Key News
7.13 Zymo Research
7.13.1 Zymo Research Corporate Summary
7.13.2 Zymo Research Business Overview
7.13.3 Zymo Research Expression Competent Cells Major Product Offerings
7.13.4 Zymo Research Expression Competent Cells Revenue in Global (2016-2021)
7.13.5 Zymo Research Key News
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Corporate Summary
7.14.2 Bio-Rad Laboratories Business Overview
7.14.3 Bio-Rad Laboratories Expression Competent Cells Major Product Offerings
7.14.4 Bio-Rad Laboratories Expression Competent Cells Revenue in Global (2016-2021)
7.14.5 Bio-Rad Laboratories Key News
7.15 Bioline
7.15.1 Bioline Corporate Summary
7.15.2 Bioline Business Overview
7.15.3 Bioline Expression Competent Cells Major Product Offerings
7.15.4 Bioline Expression Competent Cells Revenue in Global (2016-2021)
7.15.5 Bioline Key News
7.16 Delphi Genetics
7.16.1 Delphi Genetics Corporate Summary
7.16.2 Delphi Genetics Business Overview
7.16.3 Delphi Genetics Expression Competent Cells Major Product Offerings
7.16.4 Delphi Genetics Expression Competent Cells Revenue in Global (2016-2021)
7.16.5 Delphi Genetics Key News
7.17 IBA GmBH
7.17.1 IBA GmBH Corporate Summary
7.17.2 IBA GmBH Business Overview
7.17.3 IBA GmBH Expression Competent Cells Major Product Offerings
7.17.4 IBA GmBH Expression Competent Cells Revenue in Global (2016-2021)
7.17.5 IBA GmBH Key News
7.18 Cell Applications
7.18.1 Cell Applications Corporate Summary
7.18.2 Cell Applications Business Overview
7.18.3 Cell Applications Expression Competent Cells Major Product Offerings
7.18.4 Cell Applications Expression Competent Cells Revenue in Global (2016-2021)
7.18.5 Cell Applications Key News
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Corporate Summary
7.19.2 BioDynamics Laboratory Business Overview
7.19.3 BioDynamics Laboratory Expression Competent Cells Major Product Offerings
7.19.4 BioDynamics Laboratory Expression Competent Cells Revenue in Global (2016-2021)
7.19.5 BioDynamics Laboratory Key News
7.20 Scarab Genomics
7.20.1 Scarab Genomics Corporate Summary
7.20.2 Scarab Genomics Business Overview
7.20.3 Scarab Genomics Expression Competent Cells Major Product Offerings
7.20.4 Scarab Genomics Expression Competent Cells Revenue in Global (2016-2021)
7.20.5 Scarab Genomics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer


List of Tables
Table 1. Expression Competent Cells Market Opportunities & Trends in Global Market
Table 2. Expression Competent Cells Market Drivers in Global Market
Table 3. Expression Competent Cells Market Restraints in Global Market
Table 4. Key Players of Expression Competent Cells in Global Market
Table 5. Top Expression Competent Cells Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Expression Competent Cells Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Expression Competent Cells Revenue Share by Companies, 2016-2021
Table 8. Global Companies Expression Competent Cells Product Type
Table 9. List of Global Tier 1 Expression Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Expression Competent Cells Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics